文献速递生殖医学

复杂嵌合囊胚在PGT中的发生率及再活检再玻璃化后的结局

Complex mosaic blastocysts after preimplantation genetic testing: prevalence and outcomes after re-biopsy and re-vitrification.
PubMed 文献 · Reprod Biomed Online · 2021-04-20

单中心回顾性研究分析2018年1月至2019年10月PGT周期,复杂嵌合囊胚(≥3条嵌合染色体)发生率为2.4%(437/17,979),与母亲年龄和形态学质量无关。89枚复杂嵌合囊胚再活检后96.6%(86/89)存活,其中61.6%(53/86)为整倍体;再玻璃化后二次复苏存活率100%(18/18),持续妊娠率38.9%(7/18),已出生6名健康婴儿。

要点

  • 复杂嵌合囊胚发生率为2.4%,与母亲年龄及形态学质量无关。
  • 再活检后61.6%的复杂嵌合囊胚为整倍体,低质量囊胚非整倍体率更高。
  • 再活检再玻璃化后可获得38.9%的持续妊娠率并已出生6名健康婴儿。

核心结论

  • 再活检可能挽救具有发育潜能的复杂嵌合囊胚用于移植,并提高患者的累积妊娠率。

研究设计与样本

  • 单中心回顾性研究,纳入2018年1月至2019年10月的PGT周期,对囊胚活检样本行下一代测序(NGS)分析。
  • 复杂嵌合囊胚定义为具有3条及以上嵌合染色体的囊胚,对冷冻的复杂嵌合囊胚进行第二轮活检、NGS分析和玻璃化。

主要发现

  • 复杂嵌合囊胚的发生率为2.4%(437/17,979)。
  • 复杂嵌合囊胚的发生率与母亲年龄和形态学质量无关。
  • 89枚复杂嵌合囊胚进行再活检,首次复苏存活率为96.6%(86/89)。
  • 再活检样本中61.6%(53/86)为整倍体,低质量囊胚的非整倍体率高于高质量囊胚。
  • 二次复苏的囊胚存活率为100%(18/18),持续妊娠率为38.9%(7/18),并出生6名健康婴儿。

临床怎么用

  • 对于检出复杂嵌合的囊胚,可考虑再活检以筛选整倍体胚胎进行移植。
  • 再活检后的整倍体囊胚可再次玻璃化保存,复苏后用于胚胎移植。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: What is the incidence of complex mosaic in preimplantation genetic testing (PGT) blastocysts and can it be managed in clinical practice? DESIGN: A retrospective study of PGT cycles conducted between January 2018 and October 2019 at a single centre. Biopsies of blastocysts were collected and analysed by next-generation sequencing (NGS). Complex mosaic blastocysts were defined as those with three or more mosaic chromosomes. The cryopreserved complex mosaic blastocysts underwent a second round of biopsy, NGS analysis and vitrification. The euploid blastocysts identified by the re-biopsy were warmed again for embryo transfer. The main outcomes included the prevalence of the complex mosaic and the ongoing pregnancy rate. RESULTS: The prevalence of the complex mosaic was 2.4% (437/17,979). The prevalence of the complex mosaic was not associated with maternal age and morphological quality. A total of 89 complex mosaic blastocysts underwent re-biopsy and 96.6% (86/89) survived the first warming. For the re-biopsy samples, 61.6% (53/86) were euploid. The poor-quality blastocysts had higher rates of aneuploidy compared with good-quality blastocysts. The survival rate for blastocysts undergoing the second warming was 100% (18/18) and resulted in an ongoing pregnancy rate of 38.9% (7/18) as well as the birth of six healthy infants. CONCLUSION: Re-biopsy may rescue blastocysts with development potential for transfer and improve the cumulative pregnancy rate per stimulation cycle in patients containing complex mosaic blastocysts.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Zhou S, Xie P, Zhang S, et al. Complex mosaic blastocysts after preimplantation genetic testing: prevalence and outcomes after re-biopsy and re-vitrification. Reprod Biomed Online. 2021. PMID: 34193357. doi:10.1016/j.rbmo.2021.04.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。